VIR

$0.00

(

0.00%

)
Quote details

stock

Vir Biotechnology Inc

NASDAQ | VIR

5.80

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$843.22M

Market Cap

-

P/E Ratio

-4.01

EPS

$14.45

52 Week High

$4.15

52 Week Low

HEALTHCARE

Sector

VIR Chart

Recent Chart
Price Action

VIR Technicals

Tags:

VIR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $73M
Total Revenue $74M
Cost Of Revenue $845K
Costof Goods And Services Sold $845K
Operating Income -$587M
Selling General And Administrative $119M
Research And Development $506M
Operating Expenses $661M
Investment Income Net -
Net Interest Income $72M
Interest Income $72M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $15M
Income Before Tax -$523M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$522M
Comprehensive Income Net Of Tax -
Ebit -$552M
Ebitda -$538M
Net Income -$522M

Revenue & Profitability

Earnings Performance

VIR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.4B
Total Current Assets $1B
Cash And Cash Equivalents At Carrying Value $223M
Cash And Short Term Investments $223M
Inventory -
Current Net Receivables $5.1M
Total Non Current Assets $356M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $8.1M
Intangible Assets Excluding Goodwill $8.1M
Goodwill $17M
Investments -
Long Term Investments $190M
Short Term Investments $678M
Other Current Assets $47M
Other Non Current Assets -
Total Liabilities $248M
Total Current Liabilities $120M
Current Accounts Payable $5.1M
Deferred Revenue -
Current Debt -
Short Term Debt $7.8M
Total Non Current Liabilities $129M
Capital Lease Obligations $98M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $98M
Other Current Liabilities $94M
Other Non Current Liabilities $39M
Total Shareholder Equity $1.2B
Treasury Stock -
Retained Earnings -$760M
Common Stock $14K
Common Stock Shares Outstanding $136M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$446M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $15M
Capital Expenditures $7.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $499M
Cashflow From Financing $4.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$522M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $73M
Total Revenue $74M
Cost Of Revenue $845K
Costof Goods And Services Sold $845K
Operating Income -$587M
Selling General And Administrative $119M
Research And Development $506M
Operating Expenses $661M
Investment Income Net -
Net Interest Income $72M
Interest Income $72M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $15M
Income Before Tax -$523M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$522M
Comprehensive Income Net Of Tax -
Ebit -$552M
Ebitda -$538M
Net Income -$522M

VIR News

VIR Profile

Vir Biotechnology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vir Biotechnology, Inc. is a clinical-stage immunology company headquartered in San Francisco, California, focused on leveraging its proprietary technologies to develop therapeutic solutions for serious infectious diseases. With a robust pipeline targeting viral pathogens, including its innovative monoclonal antibodies and immunotherapeutics, Vir aims to address unmet medical needs in areas such as COVID-19 and influenza. The company's strategic partnerships and collaborations enhance its research capabilities, positioning it as a key player in the biotechnology sector dedicated to improving global health outcomes.

VHAI
0.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
NAYA
+85.67%
$1.40
IVF
+85.67%
$1.40
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
YDKG
-49.73%
$0.09
NVDA
+1.10%
$181.81
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
BBD
+1.87%
$3.26
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
DFLI
-32.48%
$1.33
AMD
-1.69%
$234.56
AXDX
-61.36%
$0.03
ETHD
+5.82%
$4.00
GDXD
-10.23%
$0.60
RIG
-2.41%
$3.23
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
CLF
-2.79%
$13.56
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
AMC
-2.48%
$2.75
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
ABAT
-36.64%
$5.67
QS
-13.38%
$15.46
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
NAK
-15.15%
$2.24
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
CIFR
-10.98%
$18.72
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
UUUU
-13.20%
$21.69
CRML
-14.52%
$19.42
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
MU
+5.51%
$202.53
AMZN
-0.51%
$214.47
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.83%
$47.64
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
HIMS
-5.75%
$59.15
ADD
-25.47%
$0.05
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
SLNH
-2.33%
$4.19
JOBY
-8.69%
$16.07
CRWV
+1.79%
$141.74
TOVX
-48.67%
$0.43
IONQ
-9.41%
$65.59
SATL
-29.71%
$2.91
SRM
+53.27%
$10.30
VHAI
0.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
NAYA
+85.67%
$1.40
IVF
+85.67%
$1.40
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
YDKG
-49.73%
$0.09
NVDA
+1.10%
$181.81
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
BBD
+1.87%
$3.26
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
DFLI
-32.48%
$1.33
AMD
-1.69%
$234.56
AXDX
-61.36%
$0.03
ETHD
+5.82%
$4.00
GDXD
-10.23%
$0.60
RIG
-2.41%
$3.23
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
CLF
-2.79%
$13.56
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
AMC
-2.48%
$2.75
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
ABAT
-36.64%
$5.67
QS
-13.38%
$15.46
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
NAK
-15.15%
$2.24
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
CIFR
-10.98%
$18.72
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
UUUU
-13.20%
$21.69
CRML
-14.52%
$19.42
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
MU
+5.51%
$202.53
AMZN
-0.51%
$214.47
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.83%
$47.64
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
HIMS
-5.75%
$59.15
ADD
-25.47%
$0.05
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
SLNH
-2.33%
$4.19
JOBY
-8.69%
$16.07
CRWV
+1.79%
$141.74
TOVX
-48.67%
$0.43
IONQ
-9.41%
$65.59
SATL
-29.71%
$2.91
SRM
+53.27%
$10.30

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.